Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation

Detalles Bibliográficos
Autores principales: Schönefeldt, C, Sockel, K, Wehner, R, Sopper, S, Wolf, D, Wermke, M, Thiede, C, Oelschlägel, U, Ehninger, G, Bornhäuser, M, Platzbecker, U, Schmitz, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763388/
https://www.ncbi.nlm.nih.gov/pubmed/23995045
http://dx.doi.org/10.1038/bcj.2013.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763388/
https://www.ncbi.nlm.nih.gov/pubmed/23995045
http://dx.doi.org/10.1038/bcj.2013.35

Ejemplares similares